Laboratory Corp. of America Holdings  

(Public, NYSE:LH)   Watch this stock  
Find more results for LH
99.63
+0.66 (0.67%)
May 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 98.49 - 99.72
52 week 81.56 - 99.72
Open 98.80
Vol / Avg. 0.00/932,322.00
Mkt cap 9.26B
P/E 16.85
Div/yield     -
EPS 5.91
Shares 92.90M
Beta 0.62
Inst. own 103%
Jul 19, 2013
Q2 2013 Laboratory Corporation of America Holdings Earnings Release Add to calendar
May 14, 2013
Laboratory Corporation of America Holdings at Bank of America Merrill Lynch Health Care Conference
May 8, 2013
Laboratory Corporation of America Holdings Annual Shareholder Meeting - Webcast
Apr 19, 2013
Q1 2013 Laboratory Corporation of America Holdings Earnings Conference Call - Webcast
Mar 12, 2013
Laboratory Corporation of America Holdings at Barclays Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 10.24% 10.31%
Operating margin 18.18% 18.05%
EBITD margin - 22.79%
Return on average assets 8.86% 9.06%
Return on average equity 21.49% 22.34%
Employees 34,000 -
Carbon Disclosure Rating - -

Address

358 South Main Street
BURLINGTON, NC 27215
United States - Map
+1-336-5845171 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.

Officers and directors

David P. King Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
William B. Hayes Chief Financial Officer, Executive Vice President, Treasurer
Age: 47
Bio & Compensation  - Reuters
James T. Boyle Jr. Chief Operating Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
F. Samuel Eberts III Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
Age: 53
Bio & Compensation  - Reuters
Mark Elliott Brecher M.D. Senior Vice President, Chief Medical Officer
Age: 57
Bio & Compensation  - Reuters
Robert E. Mittelstaedt Jr. Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Kerrii B. Anderson Independent Director
Age: 55
Bio & Compensation  - Reuters
Jean-Luc Belingard Independent Director
Age: 64
Bio & Compensation  - Reuters
Wendy E. Lane Independent Director
Age: 62
Bio & Compensation  - Reuters
Peter M. Neupert Independent Director
Age: 56
Bio & Compensation  - Reuters